NFMMC opens center for administering monoclonal COVID-19 antibody therapy

Niagara Falls Memorial Medical Center
Posted at 1:42 PM, Dec 09, 2020
and last updated 2020-12-09 13:42:42-05

NIAGARA FALLS, N.Y. (WKBW) — Niagara Falls Memorial Medical Center announced on Wednesday it has opened up a center for administering monoclonal COVID-19 antibody therapy.

According to the medical center, this form of therapy is authorized for the treatment of mild to moderate COVID-19 patients who are at high risk of progressing to severe COVID-19 or hospitalization.

“To enhance safety for all our patients the new center is located in a remote area of the hospital and has its own entry and exit,” said President & CEO Joseph A. Ruffolo.

“This treatment isn’t for everybody,” said Rajinder Bajwa, M.D., chief of Memorial’s infectious diseases division. “At this point we see administering it as a way to keep COVID-19 patients out of the hospital.”

Eligible patients include the following

  • Have tested positive for COVID-19 within 10 days of the onset of their symptoms
  • Are least 12 years old and weigh at least 88 pounds
  • Are at high risk for progressing to severe COVID-19 and/or hospitalization

You can learn more by contacting your primary care provider or by calling Niagara Falls Memorial Medical Center’s infectious disease clinic at (716) 278-4820.